FIJYX
Price
$29.21
Change
+$0.38 (+1.32%)
Updated
Jun 6 closing price
Net Assets
1.28B
PRHSX
Price
$76.54
Change
+$0.54 (+0.71%)
Updated
Jun 6 closing price
Net Assets
11.28B
Interact to see
Advertisement

FIJYX vs PRHSX

Header iconFIJYX vs PRHSX Comparison
Open Charts FIJYX vs PRHSXBanner chart's image
Fidelity Advisor Biotechnology Z
Price$29.21
Change+$0.38 (+1.32%)
VolumeN/A
Net Assets1.28B
T. Rowe Price Health Sciences
Price$76.54
Change+$0.54 (+0.71%)
VolumeN/A
Net Assets11.28B
FIJYX vs PRHSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIJYX vs. PRHSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIJYX is a Buy and PRHSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRHSX has more cash in the bank: 11.3B vs. FIJYX (1.28B). FIJYX pays higher dividends than PRHSX: FIJYX (3.18) vs PRHSX (0.01). FIJYX was incepted earlier than PRHSX: FIJYX (7 years) vs PRHSX (29 years). PRHSX (0.80) is less costly to investors than FIJYX (0.58). FIJYX is a more actively managed with annual turnover of: 73.00 vs. PRHSX (52.40). FIJYX has a lower initial minimum investment than PRHSX: FIJYX (0) vs PRHSX (2500). FIJYX annual gain was more profitable for investors over the last year : -7.24 vs. PRHSX (-19.26). FIJYX return over 5 years is better than : -7.36 vs. PRHSX (-11.00).
FIJYXPRHSXFIJYX / PRHSX
Total Expense Ratio0.580.8072%
Annual Report Gross Expense Ratio0.580.8072%
Fund Existence7 years29 years-
Gain YTD-3.675-4.43983%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B11.3B11%
Annual Yield % from dividends3.180.0134,490%
Returns for 1 year-7.24-19.2638%
Returns for 3 years32.11-12.69-253%
Returns for 5 years-7.36-11.0067%
Returns for 10 yearsN/A-4.90-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGEBX75.210.72
+0.97%
American Funds Growth Fund of Amer R2E
LAMQX23.54N/A
N/A
Lord Abbett Dividend Growth R2
GSRCX11.53N/A
N/A
Goldman Sachs Rising Dividend Gr C
JNPSX20.90N/A
N/A
Janus Henderson Small Cap Value D
JEVIX9.48N/A
N/A
JHancock Disciplined Value Em Mkts Eq I